Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia

被引：0
|
作者：
Shin Ahn
Yoon-Seon Lee
Kyung Soo Lim
Jae-Lyun Lee
机构：
[1] University of Ulsan College of Medicine,Cancer Emergency Room, Department of Emergency Medicine, Asan Medical Center
[2] University of Ulsan College of Medicine,Department of Oncology, Asan Medical Center
来源：
Supportive Care in Cancer | 2013年 / 21卷
关键词：
Procalcitonin; Febrile neutropenia; Bacteremia; Septic shock;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2303 / 2308
页数：5
相关论文
共 50 条
  • [21] Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients
    Viana, Luciano de Souza
    Serufo, Jose Carlos
    da Costa Rocha, Manoel Otavio
    Costa, Renato Nogueira
    Duarte, Roberto Carlos
    SUPPORTIVE CARE IN CANCER, 2008, 16 (07) : 841 - 846
  • [22] Infections in patients with febrile neutropenia: Epidemiology, microbiology, and risk stratification
    Viscoli, C
    Varnier, O
    Machetti, M
    CLINICAL INFECTIOUS DISEASES, 2005, 40 : S240 - S245
  • [23] Effect of serum albumin/globulin ratio in combination with MASCC and CISNE risk score on febrile neutropenia mortality
    Yazici, O.
    Sutcuoglu, O.
    Akdogan, O.
    Inci, B. Kurt
    Gurler, F.
    Yildirim, N. Ozdemir
    ANNALS OF ONCOLOGY, 2020, 31 : S1053 - S1053
  • [24] The suggestion of a risk stratification system for febrile neutropenia in patients with hematologic disease
    Park, Yong
    Kim, Dae Sik
    Park, Seh Jong
    Seo, Hee Yun
    Lee, Se Ryeon
    Sung, Hwa Jung
    Park, Kyong Hwa
    Choi, In Keun
    Kim, Seok Jin
    Oh, Sang Cheul
    Seo, Jae Hong
    Choi, Chul Won
    Kim, Byung Soo
    Shin, Sang Won
    Kim, Yeul Hong
    Kim, Jun Suk
    LEUKEMIA RESEARCH, 2010, 34 (03) : 294 - 300
  • [25] Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
    Terbuch, Angelika
    Posch, Florian
    Partl, Richard
    Zurl, Brigitte
    Bauernhofer, Thomas
    Pichler, Martin
    Szkandera, Joanna
    Hutterer, Georg C.
    Pummer, Karl
    Kapp, Karin S.
    Stoeger, Herbert
    Gerger, Armin
    Stotz, Michael
    CANCER MEDICINE, 2018, 7 (02): : 508 - 514
  • [26] Prediction of outcome in cancer patients with febrile neutropenia:: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10
    Uys, A.
    Rapoport, B. L.
    Fickl, H.
    Meyer, P. W. A.
    Anderson, R.
    EUROPEAN JOURNAL OF CANCER CARE, 2007, 16 (06) : 475 - 483
  • [27] SIGNIFICANCE OF FEBRILE NEUTROPENIA RISK SCORE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Vidovic, A.
    Virijevic, M.
    Djunic, I.
    Tomin, D.
    Vukovic, N. Suvajdzic
    Colovic, N.
    Mitrovic, M.
    Arsenijevic, V. Arsic
    Pavlovic, S.
    Mihaljevic, B.
    HAEMATOLOGICA, 2014, 99 : 574 - 575
  • [28] Clinical Score for Risk Stratification in Febrile Thrombocytopenia
    Manoj, A. G.
    Prabhakar, K.
    Raveesha, A.
    Hamsa, B. T.
    Anitha, A.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (05) : OC09 - OC13
  • [29] Circulating biomarkers for risk stratification of cancer patients with chemotherapy associated febrile neutropenia
    Wikstrom Fernandez, S.
    Torrella Esteban, P.
    Murillo Herrera, A.
    Garrido Ortega, P.
    Feliciangeli, E.
    Cerezuela-Fuentes, P.
    de Guadianae-Romualdo, L. Garcia
    ANNALS OF ONCOLOGY, 2024, 35 : S1095 - S1096
  • [30] EVALUATION OF THE COMPLICATION RATE AND COST OF TREATMENT ACCORDING TO THE MASCC INDEX IN PATIENTS WITH FEBRILE NEUTROPENIA
    Borget, I
    Bonnet, P.
    Gachot, B.
    Di Palma, M.
    Antoun, S.
    Merad, M.
    VALUE IN HEALTH, 2009, 12 (07) : A267 - A267
12345